Clinical Trial Update: Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing levonorgestrel-releasing intrauterine system (LNG-IUS) with depot medroxyprogesterone acetate (DMPA) for pelvic pain in endometri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Depot-medroxyprogesterone acetate (DMPA) (medroxyprogesterone acetate)
• Levonorgestrel-releasing intrauterine system (LNG-IUS) (Levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: King Chulalongkorn Memorial Hospital | Conditions: Endometriosis | Phase 4 | Status: COMPLETED